FT商学院

The Covid-era tech that could reinvent cancer care
可重塑癌症护理的新冠时代技术

Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology
新冠时代的明星BioNTech和Moderna在寻求将其突破性技术应用于肿瘤学时还面临一些障碍。

Steve Haycock had most of his colon removed last year but doctors have told the 43-year-old that his bowel cancer is highly likely to come back — unless a personalised vaccine trial pays off.

史蒂夫•海科克(Steve Haycock)去年切除了大部分结肠,但医生告诉这位43岁的患者,他的肠癌很有可能复发,除非个性化疫苗试验取得成功。

您已阅读2%(263字),剩余98%(15192字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×